Showing results (271-280 of 322) with videos related to

Sort By:
Pageof 33
Neurosurgery|August 4, 2019
Frameless Stereotactic Radiosurgery on the Gamma Knife Icon: Early Experience From 100 PatientsHoria Vulpe, Akshay V Save, Yuanguang Xu, et al.
British Journal of Cancer|November 13, 2008
TEAD1 and c-Cbl are novel prostate basal cell markers that correlate with poor clinical outcome in prostate cancerJ F Knight, C J Shepherd, S Rizzo, et al.
Molecular Cancer Therapeutics|May 5, 2012
The association of PI3 kinase signaling and chemoresistance in advanced ovarian cancerCraig P Carden, Adam Stewart, Parames Thavasu, et al.
Biorxiv : the Preprint Server for Biology|February 20, 2025
Directed Evolution of a Plant Immune Receptor for Broad Spectrum Effector RecognitionEllen Y Rim, Oscar D Garrett, Alexander J Howard, et al.
BMC Veterinary Research|June 12, 2015
Maintenance therapy with toceranib following doxorubicin-based chemotherapy for canine splenic hemangiosarcomaHeather L Gardner, Cheryl A London, Roberta A Portela, et al.
RSC Medicinal Chemistry|August 26, 2024
Synthesis and cytotoxic activity of madecassic acid-silybin conjugate compounds in liver cancer cellsChien Van Tran, Thao Thi Phuong Tran, Anh The Nguyen, et al.
Neuron|January 9, 2025
Toward a functional future for the cognitive neuroscience of human agingZoya Mooraj, Alireza Salami, Karen L Campbell, et al.
Bioorganic & Medicinal Chemistry Letters|June 22, 2010
Design and evaluation of 3,6-di(hetero)aryl imidazo[1,2-a]pyrazines as inhibitors of checkpoint and other kinasesThomas P Matthews, Tatiana McHardy, Suki Klair, et al.
Molecular Cancer Therapeutics|January 8, 2010
The preclinical pharmacology and therapeutic activity of the novel CHK1 inhibitor SAR-020106Michael I Walton, Paul D Eve, Angela Hayes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 8, 2005
In vitro and in vivo pharmacokinetic-pharmacodynamic relationships for the trisubstituted aminopurine cyclin-dependent kinase inhibitors olomoucine, bohemine and CYC202Florence I Raynaud, Steven R Whittaker, Peter M Fischer, et al.
Pageof 33